CareDx sharpens precision medicine focus with $260m Naveris acquisition
CareDx’s plans to acquire Naveris follow the divestment of its lab products business earlier this month, reporting flat revenue for…
Featured s
Medtronic receives CE mark for Stealth surgical platform
The Stealth AXiS platform supports customisable adoption based on each hospital’s needs.
All Articles
CareDx sharpens precision medicine focus with $260m Naveris acquisition
CareDx’s plans to acquire Naveris follow the divestment of its lab products business earlier this month, reporting flat revenue for…
Medtronic receives CE mark for Stealth surgical platform
The Stealth AXiS platform supports customisable adoption based on each hospital’s needs.
FDA approves Avatar Medical’s 3D image processing software
Avatar’s software translates CT and MR imaging data into 3D images to streamline surgical planning and operating room workflows.
Abbott secures FDA approval for Ultreon 3.0 imaging platform
Ultreon 3.0 uses AI and OCT to provide real-time, high-resolution imaging during minimally invasive heart procedures.
High-quality steel: A prerequisite for safer surgical procedures
Surgical instrument performance depends on the quality of the steel, with purity, durability, and biocompatibility directly influencing infection risk, longevity,…
Thermo Fisher agrees to sell microbiology business to Astorg in $1bn deal
According to GlobalData analyst Dr Andrew S Thompson, the deal signals Thermo Fisher’s move away from the IVD space.
Merck KGaA and Remepy join forces to develop combo drug-digital therapies
The pair will develop drug-digital therapeutic combinations as a singular product, thus sidestepping reimbursement hurdles linked to individually approved digital…
iRhythm demonstrates value in 14-day monitoring for arrhythmia recurrence
Two retrospective studies detected arrhythmias beyond 48 hours in 30% of patients post cardiac ablation and in 60% of pregnant…
Tandem secures FDA approval for Control-IQ+ use in pregnancy
The approval is based on findings from the CIRCUIT trial published in JAMA in October 2025.
Nervonik closes $52.5m Series B funding to advance PNS system
The funds will support further development of Nervonik’s sensing technology and commercialisation of its PNS platform.
